Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients

An Pan, Wendy Demark-Wahnefried, Xingwang Ye, Zhijie Yu, Huaixing Li, Qibin Qi, Jianqin Sun, Yanqiu Chen, Xiafei Chen, Yong Liu, Xu Lin

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Elevated C-reactive protein (CRP), IL-6 and retinol-binding protein 4 (RBP4) levels are associated with insulin resistance and diabetes mellitus. Phytoestrogens (including lignans and isoflavones) may enhance the management of diabetes and are hypothesized to act through inflammation pathways. The present study explored the effects of flaxseed-derived lignan on inflammatory factors and RBP4 concentrations in type 2 diabetics, who have higher levels of these biomarkers. Seventy community-dwelling diabetic patients (twenty-six men and forty-four post-menopausal women) with mild hypercholesterolaemia completed a randomized, double-blind, placebo-controlled, cross-over trial of supplementation with flaxseed-derived lignan capsules (360 mg/d) or placebo for 12 weeks, separated by an 8-week wash-out period. The participants maintained their habitual diets and levels of physical activity. Baseline to follow-up concentrations of CRP increased significantly within the placebo group (1.42 (SEM 0.19) v. 1.96 (SEM 0.22) mg/l, P < 0.001), but were comparatively unchanged in the lignan-supplemented group (1.67 (SEM 0.19) v. 1.90 (SEM 0.26) mg/l, P = 0.94); a significant difference was observed between treatments (-0.45 (95% CI -0.76, -0.08) mg/l, P = 0.021). This effect was confined to women (P = 0.016), but not observed in men (P = 0.49). No between-treatment differences were found with regard to IL-6 or RBP4; though IL-6 concentrations increased significantly from baseline to follow-up in both groups (P = 0.004 and P < 0.001 following lignan and placebo treatments, respectively). The study suggests that lignan might modulate CRP levels in type 2 diabetics. These results need to be confirmed by further large clinical trials of longer duration.

Original languageEnglish (US)
Pages (from-to)1145-1149
Number of pages5
JournalBritish Journal of Nutrition
Volume101
Issue number8
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Flax
Retinol-Binding Proteins
Lignans
C-Reactive Protein
Interleukin-6
Placebos
Independent Living
Phytoestrogens
Isoflavones
Hypercholesterolemia
Cross-Over Studies
Capsules
Insulin Resistance
Diabetes Mellitus
Therapeutics
Biomarkers
Clinical Trials
Exercise
Diet
Inflammation

Keywords

  • C-reactive protein
  • Flaxseed
  • IL-6
  • Inflammation
  • Lignan
  • Retinol-binding protein 4
  • Type 2 diabetes

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients. / Pan, An; Demark-Wahnefried, Wendy; Ye, Xingwang; Yu, Zhijie; Li, Huaixing; Qi, Qibin; Sun, Jianqin; Chen, Yanqiu; Chen, Xiafei; Liu, Yong; Lin, Xu.

In: British Journal of Nutrition, Vol. 101, No. 8, 2009, p. 1145-1149.

Research output: Contribution to journalArticle

Pan, An ; Demark-Wahnefried, Wendy ; Ye, Xingwang ; Yu, Zhijie ; Li, Huaixing ; Qi, Qibin ; Sun, Jianqin ; Chen, Yanqiu ; Chen, Xiafei ; Liu, Yong ; Lin, Xu. / Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients. In: British Journal of Nutrition. 2009 ; Vol. 101, No. 8. pp. 1145-1149.
@article{d8cd475cebd041049b448f4d3d48f538,
title = "Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients",
abstract = "Elevated C-reactive protein (CRP), IL-6 and retinol-binding protein 4 (RBP4) levels are associated with insulin resistance and diabetes mellitus. Phytoestrogens (including lignans and isoflavones) may enhance the management of diabetes and are hypothesized to act through inflammation pathways. The present study explored the effects of flaxseed-derived lignan on inflammatory factors and RBP4 concentrations in type 2 diabetics, who have higher levels of these biomarkers. Seventy community-dwelling diabetic patients (twenty-six men and forty-four post-menopausal women) with mild hypercholesterolaemia completed a randomized, double-blind, placebo-controlled, cross-over trial of supplementation with flaxseed-derived lignan capsules (360 mg/d) or placebo for 12 weeks, separated by an 8-week wash-out period. The participants maintained their habitual diets and levels of physical activity. Baseline to follow-up concentrations of CRP increased significantly within the placebo group (1.42 (SEM 0.19) v. 1.96 (SEM 0.22) mg/l, P < 0.001), but were comparatively unchanged in the lignan-supplemented group (1.67 (SEM 0.19) v. 1.90 (SEM 0.26) mg/l, P = 0.94); a significant difference was observed between treatments (-0.45 (95{\%} CI -0.76, -0.08) mg/l, P = 0.021). This effect was confined to women (P = 0.016), but not observed in men (P = 0.49). No between-treatment differences were found with regard to IL-6 or RBP4; though IL-6 concentrations increased significantly from baseline to follow-up in both groups (P = 0.004 and P < 0.001 following lignan and placebo treatments, respectively). The study suggests that lignan might modulate CRP levels in type 2 diabetics. These results need to be confirmed by further large clinical trials of longer duration.",
keywords = "C-reactive protein, Flaxseed, IL-6, Inflammation, Lignan, Retinol-binding protein 4, Type 2 diabetes",
author = "An Pan and Wendy Demark-Wahnefried and Xingwang Ye and Zhijie Yu and Huaixing Li and Qibin Qi and Jianqin Sun and Yanqiu Chen and Xiafei Chen and Yong Liu and Xu Lin",
year = "2009",
doi = "10.1017/S0007114508061527",
language = "English (US)",
volume = "101",
pages = "1145--1149",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "8",

}

TY - JOUR

T1 - Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients

AU - Pan, An

AU - Demark-Wahnefried, Wendy

AU - Ye, Xingwang

AU - Yu, Zhijie

AU - Li, Huaixing

AU - Qi, Qibin

AU - Sun, Jianqin

AU - Chen, Yanqiu

AU - Chen, Xiafei

AU - Liu, Yong

AU - Lin, Xu

PY - 2009

Y1 - 2009

N2 - Elevated C-reactive protein (CRP), IL-6 and retinol-binding protein 4 (RBP4) levels are associated with insulin resistance and diabetes mellitus. Phytoestrogens (including lignans and isoflavones) may enhance the management of diabetes and are hypothesized to act through inflammation pathways. The present study explored the effects of flaxseed-derived lignan on inflammatory factors and RBP4 concentrations in type 2 diabetics, who have higher levels of these biomarkers. Seventy community-dwelling diabetic patients (twenty-six men and forty-four post-menopausal women) with mild hypercholesterolaemia completed a randomized, double-blind, placebo-controlled, cross-over trial of supplementation with flaxseed-derived lignan capsules (360 mg/d) or placebo for 12 weeks, separated by an 8-week wash-out period. The participants maintained their habitual diets and levels of physical activity. Baseline to follow-up concentrations of CRP increased significantly within the placebo group (1.42 (SEM 0.19) v. 1.96 (SEM 0.22) mg/l, P < 0.001), but were comparatively unchanged in the lignan-supplemented group (1.67 (SEM 0.19) v. 1.90 (SEM 0.26) mg/l, P = 0.94); a significant difference was observed between treatments (-0.45 (95% CI -0.76, -0.08) mg/l, P = 0.021). This effect was confined to women (P = 0.016), but not observed in men (P = 0.49). No between-treatment differences were found with regard to IL-6 or RBP4; though IL-6 concentrations increased significantly from baseline to follow-up in both groups (P = 0.004 and P < 0.001 following lignan and placebo treatments, respectively). The study suggests that lignan might modulate CRP levels in type 2 diabetics. These results need to be confirmed by further large clinical trials of longer duration.

AB - Elevated C-reactive protein (CRP), IL-6 and retinol-binding protein 4 (RBP4) levels are associated with insulin resistance and diabetes mellitus. Phytoestrogens (including lignans and isoflavones) may enhance the management of diabetes and are hypothesized to act through inflammation pathways. The present study explored the effects of flaxseed-derived lignan on inflammatory factors and RBP4 concentrations in type 2 diabetics, who have higher levels of these biomarkers. Seventy community-dwelling diabetic patients (twenty-six men and forty-four post-menopausal women) with mild hypercholesterolaemia completed a randomized, double-blind, placebo-controlled, cross-over trial of supplementation with flaxseed-derived lignan capsules (360 mg/d) or placebo for 12 weeks, separated by an 8-week wash-out period. The participants maintained their habitual diets and levels of physical activity. Baseline to follow-up concentrations of CRP increased significantly within the placebo group (1.42 (SEM 0.19) v. 1.96 (SEM 0.22) mg/l, P < 0.001), but were comparatively unchanged in the lignan-supplemented group (1.67 (SEM 0.19) v. 1.90 (SEM 0.26) mg/l, P = 0.94); a significant difference was observed between treatments (-0.45 (95% CI -0.76, -0.08) mg/l, P = 0.021). This effect was confined to women (P = 0.016), but not observed in men (P = 0.49). No between-treatment differences were found with regard to IL-6 or RBP4; though IL-6 concentrations increased significantly from baseline to follow-up in both groups (P = 0.004 and P < 0.001 following lignan and placebo treatments, respectively). The study suggests that lignan might modulate CRP levels in type 2 diabetics. These results need to be confirmed by further large clinical trials of longer duration.

KW - C-reactive protein

KW - Flaxseed

KW - IL-6

KW - Inflammation

KW - Lignan

KW - Retinol-binding protein 4

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=67649438787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649438787&partnerID=8YFLogxK

U2 - 10.1017/S0007114508061527

DO - 10.1017/S0007114508061527

M3 - Article

VL - 101

SP - 1145

EP - 1149

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 8

ER -